Long-acting injectables and risk for rehospitalization among patients with schizophrenia in the home care program in Taiwan

Po Chung Ju, Frank Huang Chih Chou, Te Jen Lai, Po Ya Chuang, Yung Jung Lin, Ching Wen Wendy Yang, Chao Hsiun Tang

研究成果: 雜誌貢獻文章同行評審

17 引文 斯高帕斯(Scopus)


We aimed at evaluating the relationship between medication and treatment effectiveness in a home care setting among patients with schizophrenia. Patients with schizophrenia hospitalized between 2004 and 2009 with a primary International Classification of Diseases, Ninth Revision, Clinical Modification code of 295 were identified from Psychiatric Inpatient Medical Claims Data released by the National Health Research Institute in Taiwan. Patients who joined the home care program after discharge and were prescribed long-acting injection (LAI) (the LAI group) or oral antipsychotic medications (the oral group) were included as study subjects. The final sample for the study included 810 participants in the LAI group and 945 in the oral group. Logistic regression was performed to examine the independent effect of LAI medication on the risk for rehospitalization within the 12-month observation window after controlling for patient and hospital characteristics and propensity score quintile adjustment. The unadjusted odds ratio for rehospitalization risk was 0.80 (confidence interval, 0.65-0.98) for the LAI group compared to the oral group. The adjusted odds ratio was further reduced to 0.78 (confidence interval, 0.63-0.97). Results remained unchanged when the propensity score quintiles were entered into the regression for further adjustment. In a home care setting, patients treated with long-acting antipsychotic agents are at a significantly lower risk for psychiatric rehospitalization than those treated with oral medication. Consequently, LAI home-based treatment for the prevention of schizophrenia relapse may lead to substantial clinical and economic benefits.

頁(從 - 到)23-29
期刊Journal of Clinical Psychopharmacology
出版狀態已發佈 - 2月 2014

ASJC Scopus subject areas

  • 精神病學和心理健康
  • 藥學(醫學)


深入研究「Long-acting injectables and risk for rehospitalization among patients with schizophrenia in the home care program in Taiwan」主題。共同形成了獨特的指紋。